 ATLANTA, GA, Oct. 28, 2020 GLOBE NEWSWIRE -- via NewMediaWire -- GeoVax Labs, Inc. NasdaqCM: GOVX, GOVXW GeoVax or the Company, a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announces that CEO and Chairman David Dodd will participate in an upcoming virtual webinar titled, What COVID-19 Vaccines Teach Us About All Tech Transfers. Sponsored by Outsourced Pharma the event will be held on Wednesday, November 4, 2020 at 2:00pm ET. Discussion topics include the lessons learned and best practices from the COVID-19 vaccine efforts that can be applied to technology transfers. 